In addition, the increase in Kyn production mediated by IDO through the kynurenine pathway may induce core symptoms of depression, such as anhedonia, or further transform into downstream neuroreactive metabolites such as KYNA and QUIN. The gene discussed is IDO1; the disease is depressive disorder.